nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC22A2—nephron—nephrolithiasis	0.0804	0.28	CbGeAlD
Chlorphenamine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0367	0.0823	CbGpPWpGaD
Chlorphenamine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0342	0.0767	CbGpPWpGaD
Chlorphenamine—CYP3A4—urine—nephrolithiasis	0.0208	0.0723	CbGeAlD
Chlorphenamine—CYP2D6—urine—nephrolithiasis	0.0204	0.0712	CbGeAlD
Chlorphenamine—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.018	0.0627	CbGeAlD
Chlorphenamine—SLC22A2—nephron tubule—nephrolithiasis	0.0174	0.0605	CbGeAlD
Chlorphenamine—SLC22A2—renal system—nephrolithiasis	0.0158	0.055	CbGeAlD
Chlorphenamine—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.0154	0.0536	CbGeAlD
Chlorphenamine—SLC22A2—kidney—nephrolithiasis	0.0153	0.0531	CbGeAlD
Chlorphenamine—SLC22A2—cortex of kidney—nephrolithiasis	0.0149	0.0517	CbGeAlD
Chlorphenamine—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.014	0.0621	CcSEcCtD
Chlorphenamine—Tolterodine—CHRM3—nephrolithiasis	0.0135	0.323	CrCbGaD
Chlorphenamine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0528	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0514	CcSEcCtD
Chlorphenamine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0509	CcSEcCtD
Chlorphenamine—SLC22A1—renal system—nephrolithiasis	0.0112	0.0388	CbGeAlD
Chlorphenamine—SLC22A1—kidney—nephrolithiasis	0.0108	0.0375	CbGeAlD
Chlorphenamine—Brompheniramine—CHRM3—nephrolithiasis	0.01	0.24	CrCbGaD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00911	0.0205	CbGpPWpGaD
Chlorphenamine—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00903	0.0203	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00847	0.019	CbGpPWpGaD
Chlorphenamine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00836	0.037	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00826	0.0366	CcSEcCtD
Chlorphenamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00807	0.0181	CbGpPWpGaD
Chlorphenamine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00791	0.035	CcSEcCtD
Chlorphenamine—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00759	0.017	CbGpPWpGaD
Chlorphenamine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00753	0.0334	CcSEcCtD
Chlorphenamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0075	0.0168	CbGpPWpGaD
Chlorphenamine—CYP3A5—nephron tubule—nephrolithiasis	0.00745	0.0259	CbGeAlD
Chlorphenamine—Chlorprothixene—CHRM3—nephrolithiasis	0.00737	0.176	CrCbGaD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00734	0.0165	CbGpPWpGaD
Chlorphenamine—SLC6A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.0071	0.0159	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00684	0.0154	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00683	0.0153	CbGpPWpGaD
Chlorphenamine—CYP3A5—renal system—nephrolithiasis	0.00677	0.0236	CbGeAlD
Chlorphenamine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00675	0.0299	CcSEcCtD
Chlorphenamine—CYP3A5—kidney—nephrolithiasis	0.00655	0.0228	CbGeAlD
Chlorphenamine—CYP3A5—cortex of kidney—nephrolithiasis	0.00638	0.0222	CbGeAlD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00636	0.0143	CbGpPWpGaD
Chlorphenamine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00619	0.0274	CcSEcCtD
Chlorphenamine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00612	0.0271	CcSEcCtD
Chlorphenamine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00611	0.0137	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00597	0.0134	CbGpPWpGaD
Chlorphenamine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00594	0.0263	CcSEcCtD
Chlorphenamine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00591	0.0262	CcSEcCtD
Chlorphenamine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00579	0.0257	CcSEcCtD
Chlorphenamine—Promazine—CHRM3—nephrolithiasis	0.00577	0.138	CrCbGaD
Chlorphenamine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00566	0.0251	CcSEcCtD
Chlorphenamine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00557	0.0247	CcSEcCtD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00546	0.0123	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00546	0.0123	CbGpPWpGaD
Chlorphenamine—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00541	0.0121	CbGpPWpGaD
Chlorphenamine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00535	0.0237	CcSEcCtD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00529	0.0119	CbGpPWpGaD
Chlorphenamine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00525	0.0233	CcSEcCtD
Chlorphenamine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00519	0.023	CcSEcCtD
Chlorphenamine—CYP3A4—renal system—nephrolithiasis	0.00508	0.0177	CbGeAlD
Chlorphenamine—Chlorpromazine—CHRM3—nephrolithiasis	0.00508	0.122	CrCbGaD
Chlorphenamine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00504	0.0223	CcSEcCtD
Chlorphenamine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00502	0.0223	CcSEcCtD
Chlorphenamine—CYP2D6—renal system—nephrolithiasis	0.005	0.0174	CbGeAlD
Chlorphenamine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00497	0.022	CcSEcCtD
Chlorphenamine—CYP3A4—kidney—nephrolithiasis	0.00491	0.0171	CbGeAlD
Chlorphenamine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0049	0.0217	CcSEcCtD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00484	0.0109	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00484	0.0109	CbGpPWpGaD
Chlorphenamine—CYP2D6—kidney—nephrolithiasis	0.00483	0.0168	CbGeAlD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00481	0.0108	CbGpPWpGaD
Chlorphenamine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00481	0.0213	CcSEcCtD
Chlorphenamine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00465	0.0206	CcSEcCtD
Chlorphenamine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00462	0.0205	CcSEcCtD
Chlorphenamine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00457	0.0203	CcSEcCtD
Chlorphenamine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00453	0.0201	CcSEcCtD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00449	0.0101	CbGpPWpGaD
Chlorphenamine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0198	CcSEcCtD
Chlorphenamine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00444	0.0197	CcSEcCtD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0044	0.00988	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0044	0.00988	CbGpPWpGaD
Chlorphenamine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0044	0.0195	CcSEcCtD
Chlorphenamine—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00432	0.00971	CbGpPWpGaD
Chlorphenamine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00424	0.0188	CcSEcCtD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00414	0.00929	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00414	0.00929	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0041	0.00921	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0041	0.00921	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00385	0.00864	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00385	0.00864	CbGpPWpGaD
Chlorphenamine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00369	0.0164	CcSEcCtD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00367	0.00823	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00367	0.00823	CbGpPWpGaD
Chlorphenamine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00352	0.0156	CcSEcCtD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00343	0.0077	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00341	0.00765	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00341	0.00765	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0034	0.00764	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0034	0.00764	CbGpPWpGaD
Chlorphenamine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0034	0.0151	CcSEcCtD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00334	0.00749	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00334	0.00749	CbGpPWpGaD
Chlorphenamine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00327	0.0145	CcSEcCtD
Chlorphenamine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00322	0.0143	CcSEcCtD
Chlorphenamine—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.00313	0.00702	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00312	0.007	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00311	0.00698	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00311	0.00698	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0031	0.00696	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0031	0.00696	CbGpPWpGaD
Chlorphenamine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00306	0.0135	CcSEcCtD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00304	0.00682	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00303	0.00681	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00302	0.00677	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00302	0.00677	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00289	0.00649	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00289	0.00649	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00279	0.00626	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00278	0.00623	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00278	0.00623	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00276	0.00621	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00274	0.00616	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00274	0.00616	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00269	0.00604	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00258	0.00579	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00256	0.00574	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00256	0.00574	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00246	0.00552	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00246	0.00552	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00245	0.00549	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00228	0.00512	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00225	0.00506	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00224	0.00502	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00224	0.00502	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00222	0.00499	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0021	0.00472	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0021	0.00472	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00209	0.00468	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00209	0.00468	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00202	0.00453	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00196	0.00439	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00196	0.00439	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00186	0.00418	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00186	0.00418	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00174	0.00391	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00174	0.00391	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00174	0.00391	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00173	0.00389	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00173	0.00389	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0017	0.00381	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0017	0.00381	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00158	0.00355	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00158	0.00355	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00158	0.00354	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00158	0.00354	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00154	0.00347	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00154	0.00347	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00149	0.00335	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00147	0.0033	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00147	0.0033	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00145	0.00326	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0014	0.00315	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0014	0.00315	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00139	0.00313	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00132	0.00295	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00131	0.00294	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00131	0.00294	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00123	0.00277	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.00119	0.00268	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00114	0.00255	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00112	0.00252	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00105	0.00235	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.00104	0.00233	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000976	0.00219	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.000974	0.00219	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000908	0.00204	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000889	0.002	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.00087	0.00195	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.000868	0.00195	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.00083	0.00186	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.000809	0.00182	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.000807	0.00181	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000739	0.00166	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000739	0.00166	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.000738	0.00166	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—APRT—nephrolithiasis	0.000738	0.00166	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000706	0.00158	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000705	0.00158	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000688	0.00154	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000688	0.00154	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000642	0.00144	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000629	0.00141	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000588	0.00132	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000583	0.00131	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000534	0.0012	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000534	0.0012	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.000534	0.0012	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000527	0.00118	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.000526	0.00118	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000501	0.00113	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.00049	0.0011	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000477	0.00107	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000477	0.00107	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000476	0.00107	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.000476	0.00107	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000447	0.001	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000443	0.000996	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000381	0.000855	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.00038	0.000853	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.00038	0.000853	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000345	0.000774	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000344	0.000773	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000328	0.000736	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000315	0.000708	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000292	0.000656	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000271	0.000608	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000248	0.000558	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000248	0.000558	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000245	0.00055	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000177	0.000398	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.00016	0.00036	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	0.000158	0.000355	CbGpPWpGaD
